| top | |
| GLIOBLASTOMA NEWSLETTER | |
Volume 2, Number 6 - 20 March 2003 |
|
|
|
|
|
Contents |
|
|
|
|
| Integrative Medicine | |
| Psychosocial Aspects | |
|
|
|
|
|
|
|
|
|
|
Dahmen
U, Gu YL, Dirsch O, Fan LM, Li J, Shen K, Broelsch CE Boswellic acid, a potent antiinflammatory drug, inhibits rejection to the same extent as high dose steroids Transplant Proc 2001 Feb-Mar;33(1-2):539-41 |
|
|
Gati
I, Bergstrom M, Csoka K, Muhr C, Carlsson J Effects of the 5-lipoxygenase inhibitors AA-863 and U-60,257 on human glioma cell lines Prostaglandins Leukot Essent Fatty Acids 1990 Jun;40(2):117-24 |
|
|
Glaser
T, Winter S, Groscurth P, Safayhi H, Sailer ER, Ammon HP, Schabet M,
Weller M Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity Br J Cancer 1999 May;80(5-6):756-65 |
|
|
Gupta
I, Parihar A, Malhotra P, Gupta S, Ludtke R, Safayhi H, Ammon HP Effects of gum resin of Boswellia serrata in patients with chronic colitis Planta Med 2001 Jul;67(5):391-5 |
|
|
Janssen
G, Bode U, Breu H, Dohrn B, Engelbrecht V, Gobel U Boswellic acids in the palliative therapy of children with progressive or relapsed brain tumors Klin Padiatr 2000 Jul-Aug;212(4):189-95 |
|
|
Jing
Y, Nakajo S, Xia L, Nakaya K, Fang Q, Waxman S, Han R Boswellic acid acetate induces differentiation and apoptosis in leukemia cell lines Leuk Res 1999 Jan;23(1):43-50 |
|
|
Safayhi
H, Mack T, Sabieraj J, Anazodo MI, Subramanian LR, Ammon HP Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase J Pharmacol Exp Ther 1992 Jun;261(3):1143-6 |
|
|
Safayhi
H, Boden SE, Schweizer S, Ammon HP Concentration-dependent potentiating and inhibitory effects of Boswellia extracts on 5-lipoxygenase product formation in stimulated PMNL Planta Med 2000 Mar;66(2):110-3 |
|
|
Singh GB, Atal CK Pharmacology of an extract of salai guggal ex-Boswellia serrata, a new non-steroidal anti-inflammatory agent Agents Actions 1986 Jun;18(3-4):407-12 |
|
|
Syrovets
T, Buchele B, Gedig E, Slupsky JR, Simmet T Acetyl-boswellic acids are novel catalytic inhibitors of human topoisomerases I and IIalpha Mol Pharmacol 2000 Jul;58(1):71-81 |
|
|
Winking
M, Sarikaya S, Rahmanian A, Jodicke A, Boker DK |
|
|
|
|
|
|
|
|
|
|
|
Lissoni P, Cangemi P, Pirato D, Roselli MG, Rovelli F,
Brivio F, Malugani F, Maestroni GJ, Conti A, Laudon M, Malysheva O, Giani L |
|
